Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency
Dedicator of cytokinesis 8 (DOCK8) deficiency is a combined immunodeficiency (CID) due to biallelic mutations in the gene encoding DOCK8. Major clinical phenomena are recurrent severe infections of the lungs and skin, atopic eczema, and predisposition to malignancy leading to a poor prognosis. Typic...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 January 2025
|
| In: |
Frontiers in immunology
Year: 2025, Jahrgang: 15, Pages: 1-11 |
| ISSN: | 1664-3224 |
| DOI: | 10.3389/fimmu.2024.1507494 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fimmu.2024.1507494 Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1507494/full 
|
| Verfasserangaben: | Sophia Trombello, Andrea Jarisch, Andre Willasch, Eva Rettinger, Julia Fekadu-Siebald, Dirk Holzinger, Roland Adelmann, Peter Bader, Shahrzad Bakhtiar |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1932092021 | ||
| 003 | DE-627 | ||
| 005 | 20250731091144.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250730s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2024.1507494 |2 doi | |
| 035 | |a (DE-627)1932092021 | ||
| 035 | |a (DE-599)KXP1932092021 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Trombello, Sophia |e VerfasserIn |0 (DE-588)1368951333 |0 (DE-627)1928478573 |4 aut | |
| 245 | 1 | 0 | |a Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency |c Sophia Trombello, Andrea Jarisch, Andre Willasch, Eva Rettinger, Julia Fekadu-Siebald, Dirk Holzinger, Roland Adelmann, Peter Bader, Shahrzad Bakhtiar |
| 246 | 3 | 3 | |a Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency |
| 246 | 3 | 3 | |a Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK eight deficiency |
| 264 | 1 | |c 28 January 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.07.2025 | ||
| 520 | |a Dedicator of cytokinesis 8 (DOCK8) deficiency is a combined immunodeficiency (CID) due to biallelic mutations in the gene encoding DOCK8. Major clinical phenomena are recurrent severe infections of the lungs and skin, atopic eczema, and predisposition to malignancy leading to a poor prognosis. Typical findings include highly elevated IgE and eosinophilia. Allogeneic hematopoietic stem cell transplantation (alloHSCT) is indicated as the only curative treatment option. We present a patient with advanced disease undergoing alloHSCT at the age of 11 years after individualized pre-treatment using dupilumab and rituximab resulting in a decrease in IgE levels and clinical improvement of the skin condition. Additionally, in a review of the literature, we summarize morbidity and outcome in DOCK8-deficient patients older than 8 years of age receiving alloHSCT. Life-threatening infections, malignancy, and disease-related complications with organ damage pre-transplant are challenging in older DOCK8-deficient patients. The therapeutic role of dupilumab in DOCK8 deficiency should be evaluated in larger studies. | ||
| 650 | 4 | |a alloHSCT | |
| 650 | 4 | |a combined immunodeficiency | |
| 650 | 4 | |a DOCK8-deficiency | |
| 650 | 4 | |a dupilumab | |
| 650 | 4 | |a omalizumab | |
| 700 | 1 | |a Jarisch, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Willasch, Andre |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rettinger, Eva |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fekadu-Siebald, Julia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holzinger, Dirk |e VerfasserIn |4 aut | |
| 700 | 1 | |a Adelmann, Roland |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bader, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bakhtiar, Shahrzad |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d Lausanne : Frontiers Media, 2010 |g 15(2025), Artikel-ID 1507494, Seite 1-11 |h Online-Ressource |w (DE-627)657998354 |w (DE-600)2606827-8 |w (DE-576)343624834 |x 1664-3224 |7 nnas |a Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency |
| 773 | 1 | 8 | |g volume:15 |g year:2025 |g elocationid:1507494 |g pages:1-11 |g extent:11 |a Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fimmu.2024.1507494 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1507494/full |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250730 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1368951333 |a Trombello, Sophia |m 1368951333:Trombello, Sophia |d 910000 |d 910500 |e 910000PT1368951333 |e 910500PT1368951333 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1932092021 |e 4750785563 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"noteIll":"Illustrationen","extent":"11 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"2010-","publisher":"Frontiers Media","dateIssuedKey":"2010","publisherPlace":"Lausanne"}],"id":{"eki":["657998354"],"zdb":["2606827-8"],"issn":["1664-3224"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Frontiers in immunology","title_sort":"Frontiers in immunology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 07.11.13"],"disp":"Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiencyFrontiers in immunology","language":["eng"],"recId":"657998354","pubHistory":["1.2010 -"],"part":{"text":"15(2025), Artikel-ID 1507494, Seite 1-11","volume":"15","extent":"11","year":"2025","pages":"1-11"}}],"name":{"displayForm":["Sophia Trombello, Andrea Jarisch, Andre Willasch, Eva Rettinger, Julia Fekadu-Siebald, Dirk Holzinger, Roland Adelmann, Peter Bader, Shahrzad Bakhtiar"]},"origin":[{"dateIssuedDisp":"28 January 2025","dateIssuedKey":"2025"}],"id":{"doi":["10.3389/fimmu.2024.1507494"],"eki":["1932092021"]},"note":["Gesehen am 30.07.2025"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1932092021","titleAlt":[{"title":"Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency"},{"title":"Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK eight deficiency"}],"person":[{"given":"Sophia","family":"Trombello","role":"aut","roleDisplay":"VerfasserIn","display":"Trombello, Sophia"},{"given":"Andrea","family":"Jarisch","role":"aut","roleDisplay":"VerfasserIn","display":"Jarisch, Andrea"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Willasch, Andre","given":"Andre","family":"Willasch"},{"family":"Rettinger","given":"Eva","display":"Rettinger, Eva","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Fekadu-Siebald","given":"Julia","display":"Fekadu-Siebald, Julia","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Holzinger, Dirk","roleDisplay":"VerfasserIn","role":"aut","family":"Holzinger","given":"Dirk"},{"family":"Adelmann","given":"Roland","roleDisplay":"VerfasserIn","display":"Adelmann, Roland","role":"aut"},{"given":"Peter","family":"Bader","role":"aut","roleDisplay":"VerfasserIn","display":"Bader, Peter"},{"role":"aut","display":"Bakhtiar, Shahrzad","roleDisplay":"VerfasserIn","given":"Shahrzad","family":"Bakhtiar"}],"title":[{"title":"Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency","title_sort":"Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency"}]} | ||
| SRT | |a TROMBELLOSCASEREPORT2820 | ||